9/22/2020 9:35:43 AM
Eli Lilly Canada: GLP-1 RA Class Represents Important Advancement In Treatment Of Type 2 Diabetes
9/18/2020 7:45:49 AM
CHMP Recommends Approval Of Lilly's Baricitinib For Moderate To Severe Atopic Dermatitis In Adults
9/17/2020 6:33:11 AM
Lilly And Amgen Announce Manufacturing Collaboration To Increase Supply For COVID-19 Therapies
9/16/2020 6:47:18 AM
Eli Lilly Reports Proof Of Concept Data For Neutralizing Antibody LY-CoV555 In COVID-19 Outpatient Setting
9/15/2020 8:08:44 AM
Lilly: FDA Grants Fast Track Designation For The Development Of Jardiance
9/14/2020 6:33:37 AM
Lilly, Incyte Announce Initial Data Emerging From Adaptive COVID-19 Treatment Trial
9/14/2020 6:02:05 AM
Innovent And Lilly Announce Results Of Six Clinical Studies Of TYVYT To Be Presented At ESMO Virtual Congress 2020
9/11/2020 6:53:13 AM
Eli Lilly: REYVOW C-V Showed Pain Freedom From Migraine Attacks At 60 Minutes And Up To 48 Hours In New Phase 3 Study
9/10/2020 6:46:38 AM
Eli Lilly Plans To Present New Data From Cancer Research Pipeline At ESMO Virtual Congress 2020
9/9/2020 6:31:56 AM
Eli Lilly Names Patrik Jonsson SVP, President Of Lilly USA And Chief Customer Officer